Mykola Tutchenko
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Mykola Tutchenko has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- D. V. Rudyk
Bogomolets National Medical University, Kyiv, Ukraine
7 shared publications - Mykola S. Besedinskyi
Bogomolets National Medical University, Kyiv, Ukraine
7 shared publications - Serhii L. Chub
Bogomolets National Medical University, Kyiv, Ukraine
6 shared publications - B. I. Slonetskyi
Національна медична академія післядипломної освіти імені П. Л. Шупика, м. Київ
4 shared publications - I. V. Verbytskyi
SHUPYK NATIONAL HEALTHCARE UNIVERSITY OF UKRAINE, KYIV, UKRAINE
3 shared publications - Andrii Lovin
Taras Shevchenko National University of Kyiv, Kyiv, Ukraine
2 shared publications
Latest Publications
- Open Access
- 27 June 2026
- Published by Publishing House Zaslavsky in EMERGENCY MEDICINE
- Vol. 22 (4) , 376-382
Mutually aggravating complications in the development of hepatorenal syndrome in decompensated portal hypertension
Background. Hepatorenal syndrome (HRS) developing in the setting of decompensated portal hypertension (PH) is characterized by progressive renal failure, elevated serum creatinine levels, and worsening oliguria. HRS occurs in approximately one-third of patients with Child-Pugh class C liver cirrhosis. The purpose was to optimize early diagnosis and treatment, as well as to identify risk factors for the development of HRS and associated mortality. Materials and methods. A total of 126 medical records of patients with decompensated PH treated at the Kyiv City Emergency Hospital and the Department of Surgery, Dental Faculty, Bogomolets National Medical University, between 2022 and 2024 were analyzed. HRS was diagnosed in 51 (40.5 %) cases. Diagnostic criteria included an increase in serum creatinine > 150 µmol/L (1.69 mg/dL) or ≥ 26.5 µmol/L (0.3 mg/dL) within 48 hours in the presence of oliguria and absence of other signs of intrinsic renal injury, particularly hematuria. Patients were divided into two groups. The first group included 24 (47.1 %) patients in whom HRS and community-acquired spontaneous bacterial peritonitis (SBP) were diagnosed within the first 24 hours, and a restrictive transfusion strategy was applied. The second group comprised 27 (52.9 %) participants in whom HRS and nosocomial SBP were diagnosed on days 3–5 of hospitalization, and a liberal transfusion strategy was used. The impact of transfusion strategy, ascites severity, and SBP as mutually aggravating factors in HRS development was assessed. Results. Analysis showed that the combination of large-volume ascites, SBP, and a liberal transfusion strategy forms an unfavorable prognostic complex associated with a significantly increased risk of mortality. HRS development was more frequently associated with large-volume ascites (70.8 %), nosocomial SBP (37.0 %), and a liberal transfusion strategy (52.9 %). Among 126 patients, 27 (21.4 %) underwent surgery. In the postoperative period, HRS developed in 1 (4.2 %) patient in the first group and in 2 (7.4 %) patients in the second group. Overall mortality was 74.5 % (n = 38), with 14 deaths (58.3 %) in the first group and 24 (88.9 %) in the second group (p = 0.03). According to ROC analysis, the model demonstrated high predictive performance for mortality (AUC = 0.909; 95% CI 0.831–0.987), confirming strong discriminative ability for risk stratification in patients with HRS. Conclusions. HRS is a severe complication of decompensated PH associated with high mortality. A liberal transfusion strategy, severe ascites, and SBP increase the risk of its development and progression. Early monitoring of urine output and serum creatinine levels is critical for timely diagnosis, prevention, and management of HRS.
- 27 June 2026
- Published by Publishing House Zaslavsky in EMERGENCY MEDICINE
- Vol. 22 (4) , 376-382
Open AccessMutually aggravating complications in the development of hepatorenal syndrome in decompensated portal hypertension
Background. Hepatorenal syndrome (HRS) developing in the setting of decompensated portal hypertension (PH) is characterized by progressive renal failure, elevated serum creatinine levels, and worsening oliguria. HRS occurs in approximately one-third of patients with Child-Pugh class C liver cirrhosis. The purpose was to optimize early diagnosis and treatment, as well as to identify risk factors for the development of HRS and associated mortality. Materials and methods. A total of 126 medical records of patients with decompensated PH treated at the Kyiv City Emergency Hospital and the Department of Surgery, Dental Faculty, Bogomolets National Medical University, between 2022 and 2024 were analyzed. HRS was diagnosed in 51 (40.5 %) cases. Diagnostic criteria included an increase in serum creatinine > 150 µmol/L (1.69 mg/dL) or ≥ 26.5 µmol/L (0.3 mg/dL) within 48 hours in the presence of oliguria and absence of other signs of intrinsic renal injury, particularly hematuria. Patients were divided into two groups. The first group included 24 (47.1 %) patients in whom HRS and community-acquired spontaneous bacterial peritonitis (SBP) were diagnosed within the first 24 hours, and a restrictive transfusion strategy was applied. The second group comprised 27 (52.9 %) participants in whom HRS and nosocomial SBP were diagnosed on days 3–5 of hospitalization, and a liberal transfusion strategy was used. The impact of transfusion strategy, ascites severity, and SBP as mutually aggravating factors in HRS development was assessed. Results. Analysis showed that the combination of large-volume ascites, SBP, and a liberal transfusion strategy forms an unfavorable prognostic complex associated with a significantly increased risk of mortality. HRS development was more frequently associated with large-volume ascites (70.8 %), nosocomial SBP (37.0 %), and a liberal transfusion strategy (52.9 %). Among 126 patients, 27 (21.4 %) underwent surgery. In the postoperative period, HRS developed in 1 (4.2 %) patient in the first group and in 2 (7.4 %) patients in the second group. Overall mortality was 74.5 % (n = 38), with 14 deaths (58.3 %) in the first group and 24 (88.9 %) in the second group (p = 0.03). According to ROC analysis, the model demonstrated high predictive performance for mortality (AUC = 0.909; 95% CI 0.831–0.987), confirming strong discriminative ability for risk stratification in patients with HRS. Conclusions. HRS is a severe complication of decompensated PH associated with high mortality. A liberal transfusion strategy, severe ascites, and SBP increase the risk of its development and progression. Early monitoring of urine output and serum creatinine levels is critical for timely diagnosis, prevention, and management of HRS.
- Open Access
- 31 March 2026
- Published by Publishing Company VIT-A-POL in General Surgery
- No. 1,p. 58-63
Hepatorenal syndrome: historical perspectives on the recognition of the problem. Review
Hepatorenal syndrome (HRS) is a severe functional complication of portal hypertension and liver cirrhosis, characterized by profound renal hemodynamic dysfunction in the absence of significant structural kidney damage and associated with high mortality. Recent studies report a 90‑day mortality of 40 – 60%, depending on disease severity and therapeutic interventions. The pathophysiology of HRS is primarily driven by marked splanchnic vasodilation, resulting in reduced effective arterial blood volume, renal vasoconstriction, and a decline in glomerular filtration rate. The association between advanced liver disease and renal dysfunction was first recognized in the 19th century, whereas a clear clinical definition of HRS emerged in the mid‑20th century. Subsequent advances led to the classification of HRS into two major types: type I, an acute, rapidly progressive form with a very poor prognosis, and type II, a more indolent form commonly associated with refractory ascites. Therapeutic strategies focus on restoring effective arterial circulation. The most evidence‑based pharmacological treatment is the combination of vasoconstrictors, particularly terlipressin, combined with albumin. Invasive approaches, including transjugular intrahepatic portosystemic shunt (TIPS), peritoneovenous shunting, albumin‑based extracorporeal liver support systems, and renal replacement therapy, are considered as supportive or bridging options in selected patients, especially those awaiting liver transplantation. Prevention of HRS is based on early infection control, avoidance of nephrotoxic agents, adequate correction of hypovolemia, and routine administration of albumin after large‑volume paracentesis. Overall, HRS represents a hallmark of advanced hepatic decompensation and requires early recognition and a multidisciplinary therapeutic approach.
- 31 March 2026
- Published by Publishing Company VIT-A-POL in General Surgery
- No. 1,p. 58-63
Open AccessHepatorenal syndrome: historical perspectives on the recognition of the problem. Review
Hepatorenal syndrome (HRS) is a severe functional complication of portal hypertension and liver cirrhosis, characterized by profound renal hemodynamic dysfunction in the absence of significant structural kidney damage and associated with high mortality. Recent studies report a 90‑day mortality of 40 – 60%, depending on disease severity and therapeutic interventions. The pathophysiology of HRS is primarily driven by marked splanchnic vasodilation, resulting in reduced effective arterial blood volume, renal vasoconstriction, and a decline in glomerular filtration rate. The association between advanced liver disease and renal dysfunction was first recognized in the 19th century, whereas a clear clinical definition of HRS emerged in the mid‑20th century. Subsequent advances led to the classification of HRS into two major types: type I, an acute, rapidly progressive form with a very poor prognosis, and type II, a more indolent form commonly associated with refractory ascites. Therapeutic strategies focus on restoring effective arterial circulation. The most evidence‑based pharmacological treatment is the combination of vasoconstrictors, particularly terlipressin, combined with albumin. Invasive approaches, including transjugular intrahepatic portosystemic shunt (TIPS), peritoneovenous shunting, albumin‑based extracorporeal liver support systems, and renal replacement therapy, are considered as supportive or bridging options in selected patients, especially those awaiting liver transplantation. Prevention of HRS is based on early infection control, avoidance of nephrotoxic agents, adequate correction of hypovolemia, and routine administration of albumin after large‑volume paracentesis. Overall, HRS represents a hallmark of advanced hepatic decompensation and requires early recognition and a multidisciplinary therapeutic approach.
- Open Access
- 20 August 2025
- Published by Publishing House Zaslavsky in EMERGENCY MEDICINE
- Vol. 21 (5) , 495-501
Dynamics of polymorphonuclear neutrophil leukocytes as a criterion of the effectiveness of treatment of spontaneous bacterial peritonitis
Background. Spontaneous bacterial peritonitis (SBP) is a life-threatening complication of decompensated liver cirrhosis (LC) with ascites and is associated with high mortality. Despite modern treatment approaches, the efficacy of empirical antibiotic therapy remains variable, particularly in nosocomial SBP, which is frequently caused by multidrug-resistant organisms. Early diagnosis and evaluation of treatment efficacy require routine paracentesis with polymorphonuclear neutrophil (PMN) count. However, the optimal PMN reduction thresholds and their prognostic significance across different SBP forms remain poorly defined. Objective: to evaluate PMN dynamics in ascitic fluid after 48 hours as a marker of response to empirical antibiotic treatment in patients with SBP and LC, and to compare this indicator between community-acquired and nosocomial SBP. Materials and methods. A prospective cohort study was conducted in 101 patients with LC and confirmed SBP, hospitalized at the Kyiv City Clinical Emergency Hospital from 2023 to 2025. They were divided into two groups: community-acquired (n = 51) and nosocomial SBP (n = 50). Diagnostic paracentesis was performed with PMN count (≥ 250 cells/mm3) and microbiological culture of ascitic fluid. Follow-up paracentesis was done after 48 hours to assess PMN dynamics. Statistical analysis was performed using Statistica v10, MedCalc v23.2.1, and Microsoft Excel. For quantitative variables, mean ± standard deviation and/or median with interquartile range were calculated. Intergroup comparisons were conducted using Student’s t-test or the Mann-Whitney U test. Categorical variables were analyzed with Pearson’s test. The prognostic value of PMN dynamics was assessed by receiver operating characteristic (ROC) analysis, with calculation of area under the ROC curve, 95% confidence intervals, Youden index, sensitivity and specificity. Results. In 31.7 % of patients, SBP was asymptomatic or presented with nonspecific symptoms, complicating diagnosis. This underscores the importance of routine paracentesis in all patients with clinically significant ascites. Overall, empirical antibiotic therapy was effective in 67.3 % of cases, with better outcomes in the community-acquired group (70.5 %) compared to the nosocomial group (48 %). Neutrophil dynamics differed significantly between groups: the average PMN reduction after 48 hours was higher in community-acquired SBP. ROC analysis showed optimal thresholds of > 36.8 % PMN reduction for community-acquired SBP and > 16 % for nosocomial SBP. Conclusions. Routine diagnostic paracentesis on admission and repeated after 48 hours should be performed regardless of SBP symptoms. PMN dynamics in the ascitic fluid after 48 hours of antibiotic therapy is a reliable marker of treatment efficacy. The findings support using different PMN thresholds depending on SBP form. Nosocomial SBP is associated with reduced treatment response, warranting broader-spectrum antibiotics from the outset, taking into account the prevalence of resistant microflora.
- 20 August 2025
- Published by Publishing House Zaslavsky in EMERGENCY MEDICINE
- Vol. 21 (5) , 495-501
Open AccessDynamics of polymorphonuclear neutrophil leukocytes as a criterion of the effectiveness of treatment of spontaneous bacterial peritonitis
Background. Spontaneous bacterial peritonitis (SBP) is a life-threatening complication of decompensated liver cirrhosis (LC) with ascites and is associated with high mortality. Despite modern treatment approaches, the efficacy of empirical antibiotic therapy remains variable, particularly in nosocomial SBP, which is frequently caused by multidrug-resistant organisms. Early diagnosis and evaluation of treatment efficacy require routine paracentesis with polymorphonuclear neutrophil (PMN) count. However, the optimal PMN reduction thresholds and their prognostic significance across different SBP forms remain poorly defined. Objective: to evaluate PMN dynamics in ascitic fluid after 48 hours as a marker of response to empirical antibiotic treatment in patients with SBP and LC, and to compare this indicator between community-acquired and nosocomial SBP. Materials and methods. A prospective cohort study was conducted in 101 patients with LC and confirmed SBP, hospitalized at the Kyiv City Clinical Emergency Hospital from 2023 to 2025. They were divided into two groups: community-acquired (n = 51) and nosocomial SBP (n = 50). Diagnostic paracentesis was performed with PMN count (≥ 250 cells/mm3) and microbiological culture of ascitic fluid. Follow-up paracentesis was done after 48 hours to assess PMN dynamics. Statistical analysis was performed using Statistica v10, MedCalc v23.2.1, and Microsoft Excel. For quantitative variables, mean ± standard deviation and/or median with interquartile range were calculated. Intergroup comparisons were conducted using Student’s t-test or the Mann-Whitney U test. Categorical variables were analyzed with Pearson’s test. The prognostic value of PMN dynamics was assessed by receiver operating characteristic (ROC) analysis, with calculation of area under the ROC curve, 95% confidence intervals, Youden index, sensitivity and specificity. Results. In 31.7 % of patients, SBP was asymptomatic or presented with nonspecific symptoms, complicating diagnosis. This underscores the importance of routine paracentesis in all patients with clinically significant ascites. Overall, empirical antibiotic therapy was effective in 67.3 % of cases, with better outcomes in the community-acquired group (70.5 %) compared to the nosocomial group (48 %). Neutrophil dynamics differed significantly between groups: the average PMN reduction after 48 hours was higher in community-acquired SBP. ROC analysis showed optimal thresholds of > 36.8 % PMN reduction for community-acquired SBP and > 16 % for nosocomial SBP. Conclusions. Routine diagnostic paracentesis on admission and repeated after 48 hours should be performed regardless of SBP symptoms. PMN dynamics in the ascitic fluid after 48 hours of antibiotic therapy is a reliable marker of treatment efficacy. The findings support using different PMN thresholds depending on SBP form. Nosocomial SBP is associated with reduced treatment response, warranting broader-spectrum antibiotics from the outset, taking into account the prevalence of resistant microflora.
- Open Access
- 1 January 2025
- Published by Sumy State University in Eastern Ukrainian Medical Journal
- Vol. 13 (1) , 299-305
GASTROINTESTINAL BLEEDING AGAINST THE BACKGROUND OF NON-CIRRHOTIC PORTAL HYPERTENSION IN A PATIENT WITH MYELOFIBROSIS (CASE REPORT)
Portal hypertension in the absence of cirrhotic transformation of the liver parenchyma is considered a rare pathology with a difficult diagnostics. Non-cirrhotic portal hypertension includes a heterogeneous group of conditions based on porto-sinusoidal vascular disease of the liver and chronic portal vein thrombosis. For a long time, the course of the disease can remain asymptomatic and is usually manifested by the development of one of the complications of portal hypertension. One of the most dangerous and often fatal complications is bleeding from varicose veins of the esophagus and stomach. The purpose of this article is to demonstrate, using the example of a clinical case, the peculiarities of diagnosis and methods of successful treatment of bleeding from esophageal phlebectasia in case of non-cirrhotic portal hypertension caused by splenic vein thrombosis. The article describes the clinical case of a 57-year-old patient with a bleeding from esophageal varices with non-cirrhotic portal hypertension caused by splenic vein thrombosis due to myelofibrosis. The patient was urgently hospitalized with symptoms of hemorrhagic shock, which required intensive care, varix ligation and hemotransfusion therapy. After stabilization of hemodynamic parameters, the patient underwent a porto-azygos disconnection operation, which included devascularization of the distal esophagus, proximal stomach, transection of the esophagus and splenectomy. Conclusions. Myeloproliferative diseases are one of the many causes of non-cirrhotic portal hypertension, which often remain unrecognized until its decompensation. The diagnosis of non-cirrhotic portal hypertension is often difficult, which directly affects the prognosis. The authors' goal was to draw attention, raise awareness, and demonstrate the pathogenetic link between these conditions, the given clinical case of surgical treatment can be a variant of medical tactics aimed at controlling bleeding from esophageal and gastric phlebectasia. The positive feature of the performed surgical intervention is the direct impact on the source of bleeding, namely, the disconnection of the portal and caval venous systems, which ensured the cessation of blood flow through the esophageal-gastric collaterals. Taking into account the risks of anticoagulant therapy in patients with portal hypertension with Portal vein thrombosis and bleeding from varicose veins of the esophagus and stomach we recommend long-term (3–6 months) anticoagulant therapy in patients with prothrombotic conditions after porto-azygos disconnection and exclusion of “dangerous” esophageal-gastric collaterals, which makes it possible to effectively control hemorrhagic complications.
- 1 January 2025
- Published by Sumy State University in Eastern Ukrainian Medical Journal
- Vol. 13 (1) , 299-305
Open AccessGASTROINTESTINAL BLEEDING AGAINST THE BACKGROUND OF NON-CIRRHOTIC PORTAL HYPERTENSION IN A PATIENT WITH MYELOFIBROSIS (CASE REPORT)
Portal hypertension in the absence of cirrhotic transformation of the liver parenchyma is considered a rare pathology with a difficult diagnostics. Non-cirrhotic portal hypertension includes a heterogeneous group of conditions based on porto-sinusoidal vascular disease of the liver and chronic portal vein thrombosis. For a long time, the course of the disease can remain asymptomatic and is usually manifested by the development of one of the complications of portal hypertension. One of the most dangerous and often fatal complications is bleeding from varicose veins of the esophagus and stomach. The purpose of this article is to demonstrate, using the example of a clinical case, the peculiarities of diagnosis and methods of successful treatment of bleeding from esophageal phlebectasia in case of non-cirrhotic portal hypertension caused by splenic vein thrombosis. The article describes the clinical case of a 57-year-old patient with a bleeding from esophageal varices with non-cirrhotic portal hypertension caused by splenic vein thrombosis due to myelofibrosis. The patient was urgently hospitalized with symptoms of hemorrhagic shock, which required intensive care, varix ligation and hemotransfusion therapy. After stabilization of hemodynamic parameters, the patient underwent a porto-azygos disconnection operation, which included devascularization of the distal esophagus, proximal stomach, transection of the esophagus and splenectomy. Conclusions. Myeloproliferative diseases are one of the many causes of non-cirrhotic portal hypertension, which often remain unrecognized until its decompensation. The diagnosis of non-cirrhotic portal hypertension is often difficult, which directly affects the prognosis. The authors' goal was to draw attention, raise awareness, and demonstrate the pathogenetic link between these conditions, the given clinical case of surgical treatment can be a variant of medical tactics aimed at controlling bleeding from esophageal and gastric phlebectasia. The positive feature of the performed surgical intervention is the direct impact on the source of bleeding, namely, the disconnection of the portal and caval venous systems, which ensured the cessation of blood flow through the esophageal-gastric collaterals. Taking into account the risks of anticoagulant therapy in patients with portal hypertension with Portal vein thrombosis and bleeding from varicose veins of the esophagus and stomach we recommend long-term (3–6 months) anticoagulant therapy in patients with prothrombotic conditions after porto-azygos disconnection and exclusion of “dangerous” esophageal-gastric collaterals, which makes it possible to effectively control hemorrhagic complications.
- Open Access
- 28 December 2024
- Published by Dnipro State Medical University in Medicni perspektivi
- Vol. 29 (4) , 94-101
Hepatorenal syndrome in decompensated portal hypertension
Hepatorenal syndrome is the development of kidney failure in patients with decompensated chronic diseases with portal hypertension. This study aimed to search for optimal methods of early diagnostics, therapeutic approaches and establishment of lethality causes in hepatorenal syndrome. The research presents the outcomes of treatment of 192 patients diagnosed with hepatorenal syndrome and undergoing inpatient care at the Municipal non-profit enterprise “Kyiv City Clinical Emergency Hospital” and the Clinic of the Department of Surgery of the Dental Faculty of the Bogomolets National Medical University between 2018 and 2023. Renal dysfunction and increased creatinine were detected in 192 (43.9%) out of 437 patients with decompensated portal hypertension, who were subsequently divided into two groups based on the degree of decompensation. The first group, comprising 57 (29.7%) patients, fell into class B according to the Child-Pugh scale and had <30 points according to the MELD scale. The second group consisted of 135 (70.3%) patients classified as class C and ≥30 points according to the MELD scale. In the treatment of hepatorenal syndrome, as well as in order to ensure an euvolemic state and prevent circulatory dysfunction, after therapeutic paracentesis, an infusion of 20% albumin solution at the rate of 6-8 g/l of evacuated ascites was used. The appointment of terlipsin in patients with portal hypertension complicated by bleeding in the presence of hepatorenal syndrome had a double effect in the form of a constrictor effect aimed both at stopping bleeding and at changing the splanchnic blood flow, which contributes to the improvement of kidney function. Stopping bleeding, eliminating the infectious factor in ascitic fluid, reducing intra-abdominal pressure, correcting biochemical parameters, and optimizing intra-abdominal blood flow were components of the treatment of hepatorenal syndrome. Depending on the combination of the number and severity of complications of portal hypertension, the number of unsatisfactory treatment results also increased. The total mortality in the development of hepatorenal syndrome was 80.2%. The primary criterion for diagnosing hepatorenal syndrome is the control of diuresis and its daily decline, coupled with an increase in creatinine levels exceeding 30 mmol/l within 48 hours.Varicose bleeding, severe ascites accompanied by intra-abdominal hypertension, and spontaneous bacterial peritonitis serve both as triggering factors for hepatorenal syndrome development and increase mortality rates.
- 28 December 2024
- Published by Dnipro State Medical University in Medicni perspektivi
- Vol. 29 (4) , 94-101
Open AccessHepatorenal syndrome in decompensated portal hypertension
Hepatorenal syndrome is the development of kidney failure in patients with decompensated chronic diseases with portal hypertension. This study aimed to search for optimal methods of early diagnostics, therapeutic approaches and establishment of lethality causes in hepatorenal syndrome. The research presents the outcomes of treatment of 192 patients diagnosed with hepatorenal syndrome and undergoing inpatient care at the Municipal non-profit enterprise “Kyiv City Clinical Emergency Hospital” and the Clinic of the Department of Surgery of the Dental Faculty of the Bogomolets National Medical University between 2018 and 2023. Renal dysfunction and increased creatinine were detected in 192 (43.9%) out of 437 patients with decompensated portal hypertension, who were subsequently divided into two groups based on the degree of decompensation. The first group, comprising 57 (29.7%) patients, fell into class B according to the Child-Pugh scale and had <30 points according to the MELD scale. The second group consisted of 135 (70.3%) patients classified as class C and ≥30 points according to the MELD scale. In the treatment of hepatorenal syndrome, as well as in order to ensure an euvolemic state and prevent circulatory dysfunction, after therapeutic paracentesis, an infusion of 20% albumin solution at the rate of 6-8 g/l of evacuated ascites was used. The appointment of terlipsin in patients with portal hypertension complicated by bleeding in the presence of hepatorenal syndrome had a double effect in the form of a constrictor effect aimed both at stopping bleeding and at changing the splanchnic blood flow, which contributes to the improvement of kidney function. Stopping bleeding, eliminating the infectious factor in ascitic fluid, reducing intra-abdominal pressure, correcting biochemical parameters, and optimizing intra-abdominal blood flow were components of the treatment of hepatorenal syndrome. Depending on the combination of the number and severity of complications of portal hypertension, the number of unsatisfactory treatment results also increased. The total mortality in the development of hepatorenal syndrome was 80.2%. The primary criterion for diagnosing hepatorenal syndrome is the control of diuresis and its daily decline, coupled with an increase in creatinine levels exceeding 30 mmol/l within 48 hours.Varicose bleeding, severe ascites accompanied by intra-abdominal hypertension, and spontaneous bacterial peritonitis serve both as triggering factors for hepatorenal syndrome development and increase mortality rates.
- Open Access
- 13 September 2024
- Published by Publishing House Zaslavsky in GASTROENTEROLOGY
- Vol. 58 (3) , 222-225
Recurrent variceal bleeding in alcoholic liver cirrhosis (a case report)
Alcoholic liver cirrhosis is widely known to doctors for its complications, including variceal bleeding from the esophagus and/or stomach. Recurrent variceal bleeding is considered a sign of decompensated portal hypertension. As fibrosis in the liver progresses, the gradient of portal pressure increases steadily, and each subsequent bleeding indicates a worsening survival prognosis. There are variety of measures available now to prevent upper gastrointestinal variceal bleeding. In the clinical case, the methods used to prevent repeated bleeding are described. Despite their use, numerous variceal bleedings were registered, which demonstrated the exceptional compensatory capabilities of the patient. In addition, long-term abstinence from the harmful factor, an alcohol, seems to be the most effective measure in this case.
- 13 September 2024
- Published by Publishing House Zaslavsky in GASTROENTEROLOGY
- Vol. 58 (3) , 222-225
Open AccessRecurrent variceal bleeding in alcoholic liver cirrhosis (a case report)
Alcoholic liver cirrhosis is widely known to doctors for its complications, including variceal bleeding from the esophagus and/or stomach. Recurrent variceal bleeding is considered a sign of decompensated portal hypertension. As fibrosis in the liver progresses, the gradient of portal pressure increases steadily, and each subsequent bleeding indicates a worsening survival prognosis. There are variety of measures available now to prevent upper gastrointestinal variceal bleeding. In the clinical case, the methods used to prevent repeated bleeding are described. Despite their use, numerous variceal bleedings were registered, which demonstrated the exceptional compensatory capabilities of the patient. In addition, long-term abstinence from the harmful factor, an alcohol, seems to be the most effective measure in this case.
- Open Access
- 12 June 2024
- Published by Publishing House Zaslavsky in GASTROENTEROLOGY
- Vol. 58 (2) , 151-156
Features of the course of hepatorenal syndrome in decompensated portal hypertension (case report)
Hepatorenal syndrome is a critical and potentially life-threatening complication in patients with advanced liver cirrhosis, characterized by the development of renal dysfunction in the absence of underlying structural kidney disease. Despite some encouraging studies of pharmacological treatments, the development of hepatorenal syndrome in people with cirrhosis implies a poor prognosis, as renal failure is usually irreversible unless a liver transplantation is performed. The purpose is to show the peculiarities of hepatorenal syndrome and the method of its successful treatment. The article describes a clinical case of hepatorenal syndrome in the postoperative period in a 54-year-old woman who was hospitalized urgently with bleeding esophageal varices. She has a history of liver cirrhosis associated with HCV and portal vein thrombosis, portal hypertension syndrome, bleeding esophageal varices, ascites. After stabilization of hemodynamic parameters, the patient underwent a portoazygous disconnection, which included devascularization of the distal esophagus, proximal stomach, and esophageal transection. The first day of the postoperative period was complicated by the development of hepatorenal syndrome. Only its timely diagnosis in decompensated portal hypertension, with the elimination of pathophysiological components of the pathological process, allows correcting this complex pathology. When draining ascites, detoxification of the body is possible, which makes it possible to partially compensate for impaired kidney function. Albumin replacement therapy helps maintain osmotic balance.
- 12 June 2024
- Published by Publishing House Zaslavsky in GASTROENTEROLOGY
- Vol. 58 (2) , 151-156
Open AccessFeatures of the course of hepatorenal syndrome in decompensated portal hypertension (case report)
Hepatorenal syndrome is a critical and potentially life-threatening complication in patients with advanced liver cirrhosis, characterized by the development of renal dysfunction in the absence of underlying structural kidney disease. Despite some encouraging studies of pharmacological treatments, the development of hepatorenal syndrome in people with cirrhosis implies a poor prognosis, as renal failure is usually irreversible unless a liver transplantation is performed. The purpose is to show the peculiarities of hepatorenal syndrome and the method of its successful treatment. The article describes a clinical case of hepatorenal syndrome in the postoperative period in a 54-year-old woman who was hospitalized urgently with bleeding esophageal varices. She has a history of liver cirrhosis associated with HCV and portal vein thrombosis, portal hypertension syndrome, bleeding esophageal varices, ascites. After stabilization of hemodynamic parameters, the patient underwent a portoazygous disconnection, which included devascularization of the distal esophagus, proximal stomach, and esophageal transection. The first day of the postoperative period was complicated by the development of hepatorenal syndrome. Only its timely diagnosis in decompensated portal hypertension, with the elimination of pathophysiological components of the pathological process, allows correcting this complex pathology. When draining ascites, detoxification of the body is possible, which makes it possible to partially compensate for impaired kidney function. Albumin replacement therapy helps maintain osmotic balance.
- 1 January 2024
- Published by Sumy State University in Eastern Ukrainian Medical Journal
- Vol. 12 (2)
SPONTANEOUS BACTERIAL PERITONITIS
Spontaneous bacterial peritonitis (SBP) is an infection of ascitic fluid, posing a severe complication in patients with portal hypertension (PH). Hospital mortality rates are exceedingly high, sometimes surpassing 85%. Only timely diagnosis and treatment can mitigate mortality and morbidity levels. Purpose. Through literature analysis and review, demonstrate the necessity, appropriateness, and efficacy of SBP treatment in patients with decompensated portal hypertension. Additionally, highlight the potential development of ascites and subsequent infections, which may not always be linked to liver cirrhosis. Materials and methods. This article conducts a literature review and assesses recommendations, findings from randomized controlled trials, meta-analyses, and other review articles published in databases such as PubMed, Scopus, Web of Science, and Google Scholar between 2000 and 2023. Outcome. Diagnostic paracentesis is recommended for all ascites patients requiring emergency care or hospitalization to ascertain SBP presence. Accurate differentiation between SBP and secondary bacterial peritonitis is crucial, as treatment approaches differ for each condition. Conclusions. Standard SBP treatment entails promptly administering broad-spectrum antibiotics, considering the potential for community-acquired or nosocomial SBP, and factoring in microbial antibiotic resistance. Given SBP's annual mortality rate surpassing 50%, liver transplantation is recommended for SBP survivors.
- 1 January 2024
- Published by Sumy State University in Eastern Ukrainian Medical Journal
- Vol. 12 (2)
SPONTANEOUS BACTERIAL PERITONITIS
Spontaneous bacterial peritonitis (SBP) is an infection of ascitic fluid, posing a severe complication in patients with portal hypertension (PH). Hospital mortality rates are exceedingly high, sometimes surpassing 85%. Only timely diagnosis and treatment can mitigate mortality and morbidity levels. Purpose. Through literature analysis and review, demonstrate the necessity, appropriateness, and efficacy of SBP treatment in patients with decompensated portal hypertension. Additionally, highlight the potential development of ascites and subsequent infections, which may not always be linked to liver cirrhosis. Materials and methods. This article conducts a literature review and assesses recommendations, findings from randomized controlled trials, meta-analyses, and other review articles published in databases such as PubMed, Scopus, Web of Science, and Google Scholar between 2000 and 2023. Outcome. Diagnostic paracentesis is recommended for all ascites patients requiring emergency care or hospitalization to ascertain SBP presence. Accurate differentiation between SBP and secondary bacterial peritonitis is crucial, as treatment approaches differ for each condition. Conclusions. Standard SBP treatment entails promptly administering broad-spectrum antibiotics, considering the potential for community-acquired or nosocomial SBP, and factoring in microbial antibiotic resistance. Given SBP's annual mortality rate surpassing 50%, liver transplantation is recommended for SBP survivors.
- Open Access
- 1 July 2021
- Published by Zaporizhzhia State Medical and Pharmaceutical University in Zaporozhye Medical Journal
- Vol. 23 (4) , 583-589
Current trends in diagnostic and treatment tactics in patients with strangulated ventral hernias
The aim of the work. To analyze the world achievements in modern diagnostic and treatment tactics in patients with strangulated ventral hernias, as well as to outline promising and pragmatic directions for further research. The literature review presents current trends and views on the choice of individual components of the integrated diagnostic approach in patients with strangulated ventral hernias, and focuses on various principles of therapeutic tactics. The need to further improve the examination methods of abdominal organs, anterior abdominal wall, hernia contents (polypositional roentgenoscopy or roentgenography, ultrasound, CT, MRI) is emphasized and prospects of allohernioplasty and videolaparoscopic technologies with an integrated approach in choosing the method for correction or reconstruction of abdominal wall depending on the prognostic risk factors of postoperative complications are substantiated. Comparison of individual priorities of planned hernia surgery provided the opportunity to define the main directions in terms of urgent medical treatment features for patients with strangulated ventral hernias, taking into account a phasal nature of the pathological process and the availability and applicability of various synthetic implants. The literature analysis allowed for enough critical evaluation of the current state of tension-free allohernioplasty - the main fundamental principle of modern urgent surgery for ventral hernias and determining the main pragmatic directions of a selective approach in choosing the therapeutic tactics for patients with infected surgical wound. Conclusions. Urgent surgery of strangulated ventral hernias requires adequate and timely provision of individual and differentiated approaches in choosing the volume and method of surgery. Improvement of methods for predicting and preventing complications in patients with strangulated ventral hernias will expand the indications for the use of advanced types of tension-free hernioplasty.
- 1 July 2021
- Published by Zaporizhzhia State Medical and Pharmaceutical University in Zaporozhye Medical Journal
- Vol. 23 (4) , 583-589
Open AccessCurrent trends in diagnostic and treatment tactics in patients with strangulated ventral hernias
The aim of the work. To analyze the world achievements in modern diagnostic and treatment tactics in patients with strangulated ventral hernias, as well as to outline promising and pragmatic directions for further research. The literature review presents current trends and views on the choice of individual components of the integrated diagnostic approach in patients with strangulated ventral hernias, and focuses on various principles of therapeutic tactics. The need to further improve the examination methods of abdominal organs, anterior abdominal wall, hernia contents (polypositional roentgenoscopy or roentgenography, ultrasound, CT, MRI) is emphasized and prospects of allohernioplasty and videolaparoscopic technologies with an integrated approach in choosing the method for correction or reconstruction of abdominal wall depending on the prognostic risk factors of postoperative complications are substantiated. Comparison of individual priorities of planned hernia surgery provided the opportunity to define the main directions in terms of urgent medical treatment features for patients with strangulated ventral hernias, taking into account a phasal nature of the pathological process and the availability and applicability of various synthetic implants. The literature analysis allowed for enough critical evaluation of the current state of tension-free allohernioplasty - the main fundamental principle of modern urgent surgery for ventral hernias and determining the main pragmatic directions of a selective approach in choosing the therapeutic tactics for patients with infected surgical wound. Conclusions. Urgent surgery of strangulated ventral hernias requires adequate and timely provision of individual and differentiated approaches in choosing the volume and method of surgery. Improvement of methods for predicting and preventing complications in patients with strangulated ventral hernias will expand the indications for the use of advanced types of tension-free hernioplasty.
- Open Access
- 28 May 2021
- Published by Publishing House Zaslavsky in EMERGENCY MEDICINE
- Vol. 17 (3) , 36-38
Elfunat in complex treatment of patients with portal hypertension in the early post-hemorrhagic period
The paper deals with the results of the study of the effect of 2-ethyl-6-methyl-3-hydroxypyridine succinate (Elfunat) on erythroid lineage in patients with alcoholic liver cirrhosis and a history of gastroesophageal variceal bleeding. The study compared the impact on the central nervous system and blood values. The results of this study are important for the management of anemia and encephalopathy in this category of patients.
- 28 May 2021
- Published by Publishing House Zaslavsky in EMERGENCY MEDICINE
- Vol. 17 (3) , 36-38
Open AccessElfunat in complex treatment of patients with portal hypertension in the early post-hemorrhagic period
The paper deals with the results of the study of the effect of 2-ethyl-6-methyl-3-hydroxypyridine succinate (Elfunat) on erythroid lineage in patients with alcoholic liver cirrhosis and a history of gastroesophageal variceal bleeding. The study compared the impact on the central nervous system and blood values. The results of this study are important for the management of anemia and encephalopathy in this category of patients.